Correction: Biotie's Financial Statement Report and Corporate Governance Statement 2014 published
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 9 March 2015
at 5:45 p.m.
Correction: Biotie's Financial Statement Report and Corporate Governance
Statement 2014 published
Biotie Therapies Corp.' s Financial Statement Report for the financial period
ended 31 December 2014 and Corporate Governance Statement 2014 have been
published. Financial statements sent earlier today attached in stock exchange
release contained a pdf file with password protection.
The documents are attached in pdf format in this release. Both documents are
also available on Biotie's website www.biotie.com in English and Finnish
language.
Turku, 9 March 2015
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail: virve.nurmi(at)biotie.com
DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com
About Biotie
Biotie is a specialized drug development company focused on products for
neurodegenerative and psychiatric disorders. Biotie's development has delivered
Selincro (nalmefene) for alcohol dependence, which received European marketing
authorization in 2013 and is currently being rolled out across Europe by partner
Lundbeck. The current development products include tozadenant for Parkinson's
disease, which is transitioning into Phase 3 development, and two additional
compounds which are in Phase 2 development for cognitive disorders including
Parkinson's disease dementia, and primary sclerosing cholangitis (PSC), a rare
fibrotic disease of the liver.
Corporate Governance Statement 2014:
http://hugin.info/132030/R/1900549/675622.pdf
Biotie_Financial_Statements 2014:
http://hugin.info/132030/R/1900549/675624.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via GlobeNewswire
[HUG#1900549]
Unternehmensinformation / Kurzprofil:
Datum: 09.03.2015 - 16:45 Uhr
Sprache: Deutsch
News-ID 377101
Anzahl Zeichen: 2612
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 126 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Correction: Biotie's Financial Statement Report and Corporate Governance Statement 2014 published"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
